Nosopharm

Nosopharm

Nosopharm

Nosopharm is a young innovative biotechnology company dedicated to anti-infective drug discovery, targeting the bacterial multidrug resistance to antibiotics.
Type
B2c
Raised
$3.8M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
€1,000,000
Debt financing - 2018
Bpifrance
€2,400,000
Venture capital - 2017
Auriga Partners Alto Invest KREAXI
Team Size
1–10
Employees
Location
Headquarters
€1,000,000 Debt financing
FinSMEs

Nosopharm Receives €1M Loan from Bpifrance

Health Science
PE HUB

French biotech firm Nosopharm attracts $2.6 mln

Funding Health Science
€2,400,000 Venture capital
FinSMEs

Nosopharm Raises €2.4M in Funding

Funding Science Health